معرفی
Natalie Diepenhorst is a Research Fellow at the Neuromedicines Discovery Centre (NDC), Monash University. She holds a PhD in Biochemistry from the University of Melbourne (2013), focusing on GPCR/ligand interactions. Her work aligns with UN Sustainable Development Goals, particularly in advancing healthcare through drug discovery.
Research Interests: Her primary areas include Drug Discovery, GPCR Biology, and Structural Biology. She investigates therapeutic targets for substance use disorders, metabolic diseases, and cancer, with a focus on G protein-coupled receptors (GPCRs) and their roles in pathophysiological processes.
Publications Trends: Recent work includes studies on colorectal cancer mechanisms linked to gut microbiota, serotonin receptors in substance use disorders, and metabolic pathways involving GPR21. Earlier research emphasized drug targets for osteoporosis and histamine receptor signaling.
- Awards:
- Advance Women's Success Grant (2023)
- ASBMB Graduate/Postdoctoral Travel Award (2011)
- ASCEPT Drug Discovery Travel Award (2016)
- Collaborations: Global networks in cancer biology, metabolic disorders, and structural biology.
Labs/Teams: Active in the NDC, contributing to interdisciplinary research in neuromedicines and translational pharmacology.
حوزههای پژوهشی
